| Literature DB >> 30995345 |
Konstantin Horas1, Yu Zheng1, Colette Fong-Yee1, Eugenie Macfarlane1, Jeline Manibo1, Yunzhao Chen1, Jeremy Qiao1, Mingxuan Gao1, Nancy Haydar2, Michelle M McDonald2, Peter I Croucher2, Hong Zhou1, Markus J Seibel1.
Abstract
Expression of the vitamin D receptor (VDR) is thought to be associated with neoplastic progression. However, the role of the VDR in breast cancer metastasis to bone and the molecular mechanisms underlying this process are unknown. Employing a rodent model (female Balb/c nu/nu mice) of systemic metastasis, we here demonstrate that knockdown of the VDR strongly increases the metastatic potential of MDA-MB-231 human breast cancer cells to bone, resulting in significantly greater skeletal tumor burden. Ablation of VDR expression promotes cancer cell mobility (migration) and invasiveness, thereby facilitating skeletal colonization. Mechanistically, these changes in tumor cell behavior are attributable to shifts in the expression of proteins involved in cell adhesion, proliferation, and cytoskeletal organization, patterns characteristic for epithelial-to-mesenchymal cell transition (EMT). In keeping with these experimental findings, analyses of human breast cancer specimens corroborated the association between VDR expression, EMT-typical changes in protein expression patterns, and clinical prognosis. Loss of the VDR in human breast cancer cells marks a critical point in oncogenesis by inducing EMT, promoting the dissemination of cancer cells, and facilitating the formation of tumor colonies in bone.Entities:
Keywords: BONE METASTASIS; BREAST CANCER; BREAST CANCER METASTASIS; VITAMIN D RECEPTOR
Year: 2019 PMID: 30995345 DOI: 10.1002/jbmr.3744
Source DB: PubMed Journal: J Bone Miner Res ISSN: 0884-0431 Impact factor: 6.741